FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Popular weightloss drug Ozempic launched in India at the price of Rs…, check dosage, more details
Danish drugmaker Novo Nordisk launched its most popular weight-loss drug Ozempic in India on Friday. The price of…